AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04895098 — intervention group
Intervention type: DRUG
Intervention: statin and ezetimibe combination therapy
Description: Receiving statins (atorvastatin/rosuvastatin or others) in combination with ezetimibe 10mg/day in a stable dosing regimen (without changing the dose of the therapy and/or replacing the statin) for 3 or more months at the time of enrolment in the study.
Study NCT04895098 — intervention group
Intervention type: DRUG
Intervention: statin monotherapy
Description: Receiving statins (atorvastatin/rosuvastatin or others) as monotherapy in a stable dosing regimen (without changing the dose of the therapy and/or replacing the statin) for 3 or more months at the time of enrolment in the study.
Study NCT04841018 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low dose dexamethasone
Description: After caudal block with 1.2ml/kg of 0.15% ropivacaine, the patient receives 0.15mg/kg of intravenous dexamethasone
Study NCT05370820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: IV 2 minutes, IV 10 minutes, IM
Study NCT05402982 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Electrical Cardiometry (EC) ICON
Description: Electrical Cardiometry (EC) ICON (Osypka Medical, Berlin, Germany) is an FDA approved device used for non-invasive measurement of some hemodynamic parameters as cardiac output,cardiac index, stroke volume,stroke volume variation, systemic vascular resistance, thoracic fluid content, ICON (index of contractility), variation of ICON,corrected flow time and systolic time ratio.The set data of EC are the height, weight,hemoglobin, Oxygen saturation(SPO2),age, gender ,blood pressure and heart rate(HR) of the patient
Study NCT05402982 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Rohrich formula
Description: Rohrich formula and the intraoperative fluid ratio (subcutaneous infiltration fluid plus intravenous fluid divided by total aspirate volume) will be 1.2
Study NCT05236920 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Resuscitative Endovascular balloon occlusion of the aorta using a REBOA catheter device
Description: In-hospital use of a REBOA catheter device during advanced cardiac life support
Study NCT05834530 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3D Printed Complete Dentures
Description: Denture bases printed from a pre-polymerized block via additive technique, using photon S desktop 3D printer\* that relies on SLA technology and post cured by post curing unit.
Study NCT05959434 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy + Relapse Prevention
Description: Cognitive-Behavioral Therapy that integrates Cognitive Processing Therapy for PTSD with Relapse Prevention for alcohol use disorder
Study NCT05959434 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Relapse Prevention
Description: Cognitive-Behavioral Therapy that targets alcohol use, specifically
Study NCT05632341 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactococcus lactis
Description: 1 capsule once a day
Study NCT05632341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: maltodextrin
Description: 1 capsule once a day
Study NCT05342415 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Internally Focused Exercise
Description: While performing the exercises participants will be instructed to focus on the muscle itself.
Study NCT05342415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Externally Focused Exercise
Description: While performing the exercises participants will be instructed to focus on the external target (towel, target line, etc.)
Study NCT05685901 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: High polyphenolic olive oil. (Early harvest olive oil).
Description: High polyphenolic olive oil is normal olive oil obtained from early harvest olives, this early harvest olive oil has been widely used for culinary purposes for centuries. The investigators wanted to study if oromucosal immunoprophylaxis with small quantities of high polyphenolic olive oil (2 mL of olive oil equivalent to 5 mg of polyphenols) adiministered twice a day could have clinical mitigating effects on the disease caused by SARS-CoV-2 infection.The primary outcome was to determine the effect of high polyphenolic olive oil on Coronavirus disease incidence, duration and severity.
Study NCT05291832 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain.fm Music
Description: Experimental arm
Study NCT05057182 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BNT162b2
Description: BNT162b2 mRNA vaccine (Cominarty®, BioNTech/Fosun Pharma), one dose (0.3mL after dilution) contains 30 micrograms of COVID-19 mRNA Vaccine embedded in lipid nanoparticles.
Study NCT05291832 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spectrally-matched Noise
Description: Active control arm
Study NCT05147038 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tele-coaching
Description: The participants are instructed to use a Fitbit fitness tracker to record the number of steps. This device is compatible with the m-PAC App, which was developed for this specific group of participants (individuals suffering from a chronic lung disease). The participants receive a feedback via the m-PAC App every day and they also receive a week report to be albe to adjust their step goal. They are asked to increase or keep their week goal every Sunday after reviewing a weekly report. The participants also receive tips for their PA improvement and they are asked for medication change specification (every Wednesday).
Study NCT05007665 — intervention group
Intervention type: BIOLOGICAL
Intervention: SARS-COV-2 VACCINE
Description: the antibody titer and adverse reactions were observed.
Study NCT04887233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Longan nasal spray
Description: The patients will be received 2 puff of Longan nasal spray 2 times/day for 3 days.
Study NCT04887233 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The patients will be received 2 puff of placebo nasal spray 2 times/day for 3 days.
Study NCT04977063 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Atmo gas capsule
Description: The Atmo Gas Capsule measures the capsules location and motility/transit times through gas sensing capabilities
Study NCT04977063 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: SmartPill
Description: The SmartPill measures the capsules location and motility/transit times through pH sensing
Study NCT05132478 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotionally Supportive Video
Description: The video is approximately 6 1/2 minutes in length and portrays an emotionally supportive conversation between a patient and surgeon during which the surgeon discusses: the diagnosis, prognosis, available treatment options, benefits and harms of the options, and need for decision making. The surgeon speaks for the majority of the simulated visit and discusses total and hemi-thyroidectomy with the addition of emotionally supportive statements and gestures.
Study NCT05132478 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Video
Description: The video is approximately 5 minutes in length and portrays a standard conversation between a patient and surgeon during which the surgeon discusses: the diagnosis, prognosis, available treatment options, benefits and harms of the options, and need for decision making. The surgeon speaks for the majority of the simulated visit and discusses total and hemi-thyroidectomy.
Study NCT05839535 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: BDJ
Description: BDJ is a mind-body intervention
Study NCT05839535 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: tDCS
Description: tDCS is a brain stimulation method.
Study NCT05839535 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: sham tDCS
Description: sham tDCS
Study NCT05839535 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: exercise including stretching and other activities.
Study NCT04326192 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Research electrode
Description: A second electrode will be placed percutaneously by Tuohy needle in the epidural space at the same time as the SCS trial implant; at lateral T1-2 area randomly assigned to the left or right side of the lateral epidural space, at the time of the procedure. Placement of electrodes is not experimental, but the placement of a second electrode is a research-driven procedure.
Study NCT05397548 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of levels of circulating exosomal lncRNA-GC1
Description: Each participant was enrolled to assess the levels of circulating exosomal lncRNA-GC1
Study NCT05369169 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resonance breathing
Description: Participants will synchronize their breathing with a visual pacer (E-Z Air, Thought Technology, Ltd., Plattsburgh, NY) that moves up (inhale) and down (exhale) at the rate of 0.1 Hz (6 breaths per min)
Study NCT05369169 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low demand cognitive task
Description: Different colored rectangles are presented for 10 sec each, and participants are instructed to silently count the number of blue rectangles
Study NCT04597658 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bodyweight supported treadmill training (BWSTT)
Description: In the BWSTT group, walking training will be given by asking the patients to walk on the treadmill as fast as they can, without exceeding the medium intensity according to the Borg scale. Bodyweight support will be gradually reduced according to the patient's tolerance.
Study NCT04597658 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rehabilitation
Description: The conventional rehabilitation program includes posture and breathing exercises, lower extremity stretching, active-assistive range of motion and strengthening, balance-coordination exercises, and walking with a physiotherapist on a smooth surface.
Study NCT05881317 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ArtiAid® Plus Intra-articular Injection
Description: Inject ArtiAid® Plus in the affected joint at weekly interval for 3 weeks
Study NCT06498336 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory examination to determine the presence of sepsis
Description: Standard laboratory biochemical methods will be used to determine sepsis diagnosis accord-ing to SEPSIS 3 (1). Blood samples for obtaining serum/plasma of the patients will be taken on the 1st and 4th day of sepsis diagnosis.
Study NCT06498336 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory examination to determine the presence of sepsis and acute kidney injury
Description: Standard laboratory biochemical methods will be used to determine sepsis diagnosis according to SEPSIS 3 and acute kidney injury according to Guidelines Kidney Disease Improving Global Outcomes (KDIGO) 2012 (2). Blood samples for obtaining serum/plasma of the patients will be taken on the 1st and 4th day of sepsis diagnosis.
Study NCT06498336 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Laboratory examination to determine miRNA and biochemical parameters
Description: Laboratory examination will be performed to determine miRNA and biochemical parameters.
Study NCT05765019 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal mobilization
Description: Spinal mobilization and core stabilization exercise
Study NCT05765019 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core stabilization exercise
Description: Stabilization exercises for the spine
Study NCT05765019 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Core stabilization exercise
Description: Stabilization exercises for the spine
Study NCT04348617 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Moderate exercise
Description: 50 minutes of moderate exercise on treadmill
Study NCT04348617 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rest
Description: 50 minutes of rest or sedentary activity
Study NCT05199142 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SDI-118
Description: SDI-118 Powder in Capsules (PiC) are presented as Drug Substance in white, size 3, hydroxypropylmethylcellulose (HPMC) capsules. No excipients are added.
Study NCT05199142 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The Matching Placebo for SDI-118 PiC is equivalent dose of mannitol (an inert excipient) in white, size 3, hydroxypropylmethylcellulose (HPMC) capsules.
Study NCT04887246 — intervention group
Intervention type: BIOLOGICAL
Intervention: COVID-19 vaccines
Description: COVID-19 vaccines available at Colombia
Study NCT06337825 — intervention group
Intervention type: BEHAVIORAL
Intervention: Activity Tracker (Fitbit)
Description: Wearable, activity tracker
Study NCT06337825 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: HbA1C
Description: Average blood glucose (sugar) levels reported as a percentage
Study NCT06337825 — intervention group
Intervention type: BEHAVIORAL
Intervention: The PROMPT Questionnaire
Description: The PROMPT Questionnaire which is a 30-question previously validated assessment for non-specific symptoms in PHPT, will be administered to patients preoperatively and at 2-weeks and 6-months postoperatively
Study NCT04333472 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Piclidenoson
Description: Piclidenoson 2 mg orally every 12 hours for up to 28 days
Study NCT04333472 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo orally every 12 hours for up to 28 days
Study NCT04950959 — intervention group
Intervention type: DEVICE
Intervention: Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. T
Description: The system is used for trajectory planning and is intended to assist the physician in the positioning of an instrument, such as a needle, where CT imaging is used for target trajectory planning and intraoperative tracking. The XACT ACE Robotic System uses a computerized quantitative guidance system, which provides real-time, accurate needle guidance, including advancement and steering of the needle from the entry point on the subject's body to the target point within the body.
Study NCT03613064 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Socially Enhanced Transitional Care Intervention
Description: Components: 1) Standardized social vulnerabilities assessment tool, to be developed and incorporated into admission workflows. 2) Electronic community service referrals to existing community resources (i.e. food banks, shelters, community rehab), via the Dallas IEP or other information technology platform, for material (food, housing) and psychosocial needs (mental health/drug treatment). 3) Community-based cardiovascular self-management interventions, to be developed and piloted in conjunction with #3 - e.g., customized 'heart healthy' food baskets for CHF/IHD; risk factor monitoring (i.e., weight and blood pressure measurement at food banks, shelters, churches, modeled on the barber shop hypertension intervention); and 'heart buddy' support groups for CHF and IHD at community sites.
Study NCT05142306 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVID-HIG
Description: Anti-SARS-CoV-2 Immunoglobulin (Human) \[COVID-HIG\] is a purified liquid immunoglobulin G (IgG) preparation
Study NCT04280003 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Alogenic adipose tissue-derived stem cells
Description: Concentration of the cells: 10 million cells / ml
Study NCT04280003 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo solution
Description: Placebo intravenous solution, same appearance stem cells solution
Study NCT06148831 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Infant Carrier
Description: The assigned home visitor will provide a participant with an infant carrier and will watch a short training video on how to use the carrier, including a demonstration of safe and ergonomic use. The home visitor will support the client to practice using the carrier and will provide materials to support continued learning.~All home visitors participated in an infant carrier training developed by Nurturely, centered on carrying as a cultural practice, utilizing culturally relevant visuals as well as easy-to-remember acronyms to promote safe and ergonomic use (i.e., the STOP acronym developed by Nurturely, signifying that all knots are Secure, infant is attached high enough to kiss the top of their head and Tight to the caregiver's body, nose and mouth are visible and airway is Open, and hips are Positioned in an ergonomic spread squat).
Study NCT05817461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0780 tablet
Description: oral, fasted
Study NCT05817461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]AZD0780 Solution for Infusion
Description: intravenous
Study NCT05817461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]AZD0780 Oral Solution
Description: oral, fasted
Study NCT04263519 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tacrolimus
Description: Oral Immunosuppressant
Study NCT05204394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VM-1500A-LAI
Description: Injectable nanoformulation of depulfavirine (parent drug of elsulfavirine)
Study NCT05204394 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: Any oral 1st line approved HIV treatment regimen
Study NCT05454410 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIJ821 Subcutaneous Injection - low dose
Description: MIJ821 supplied in vials as a powder for solution for injection, to be reconstituted, and administered as a single subcutaneous injection on Day 1
Study NCT06154018 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Protamin
Description: ACT and Clot- Pro test will be ran after initial and possible next protamine administrations
Study NCT05454410 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIJ821 Subcutaneous Injection - medium dose
Description: MIJ821 supplied in vials as a powder for solution for injection, to be reconstituted, and administered as a single subcutaneous injection on Day 1
Study NCT05454410 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MIJ821 Subcutaneous Injection - high dose
Description: MIJ821 supplied in vials as a powder for solution for injection, to be reconstituted, and administered as a single subcutaneous injection on Day 1
Study NCT05454410 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Subcutaneous Injection
Description: 0.9% sodium chloride solution to be administered as a single subcutaneous injection on Day 1
Study NCT05745792 — intervention group
Intervention type: OTHER
Intervention: Description of clinical, immunological and tumor features of patients harboring Hu Abs
Description: This observationnal study involves clinical data and bio. samples (DNA and tumors block). Demographic and clinical data already in French Reference Center on PNS database will be reviewed. Additional data will be obtained from the referral physicians. The results of diagnostic tests performed to detect Hu-Abs in the patients are already in this database and will be retrospectively analyzed. In addition, the 4 available techniques (immunofluorescence, commercial immunodot, Western blot, and CBA) will be performed from Jan. 2022 to Dec. 2022.Tumor samples from 2 cohorts will be analyzed: (i) tumors of patients with Hu-Abs and PNS, and (ii) tumors of patients without PNS (mostly SCLC). After selecting patients, the study will involve 3 steps: (i) pathological confirmation; (ii) DNA sequencing and CNV analysis (panel of genes involved in anti-Hu autoimmunity; mainly ELAVL1 to 4, encoding for HuA to HuD, the 4 main proteins of the Hu family); and (iii) whole-genome RNA sequencing.
Study NCT06224712 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arogya Sangama
Description: Using human-centered design, the investigators will work wit the community to develop a prototype Arogya Sangama model to identify methods to bring GPTF and HWC service providers to create ideas, systems, processes, services, and delivery strategies for the GPTFs. They will help identify and prioritize interventions and address barriers to usability. There will also be capacity building of GPTFs to implement the interventions identified.
Study NCT06055036 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Black Impact Intervention
Description: The Black Impact intervention is an academic-community-government partnership adapted from the Diabetes Prevention Program and American Heart Association Check, Change, Control programs based on stakeholder feedback and to afford incorporation of additional evidence-based strategies for influencing target outcomes. The intervention is a 24-week community-based lifestyle intervention to improve cardiovascular health among Black men. Each participant will be assigned to a group with >5 participants based on participant proximity to a central community meeting location. Each team will be guided weekly by a health coach who delivers content and coaching around the lifestyle intervention modeled on the diabetes prevention program and check, change, control blood pressure program, a community health worker who helps to address social needs and connects participants to primary care services, and a trainer who leads physical activity. Teams meet for 90 minutes per week.
Study NCT05087862 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-guided pericapsular nerves group of the hip block
Description: After the ultrasound-guided insertion of a block needle at the level of the inguinal ligament, the needle will be advance into the plane between the iliac bone periosteum and the tendon of the iliopsoas muscle in order to inject 20 mL of adrenalized 0.5% bupivacaine.